BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Long W, Gao M, Jiao F, Chen Z, Liu M, Yu L. TREM2 Regulates High Glucose-Induced Microglial Inflammation via the NLRP3 Signaling Pathway. Brain Sci 2021;11:896. [PMID: 34356130 DOI: 10.3390/brainsci11070896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zhang H, Long W, Gao M, Guo W, Yu L. Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo. Aging 2022. [DOI: 10.18632/aging.204363] [Reference Citation Analysis]
2 Satoh-asahara N, Yamakage H, Tanaka M, Kawasaki T, Matsuura S, Tatebe H, Akiguchi I, Tokuda T. Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of patients with diabetes based on their cognitive status. Diabetes Research and Clinical Practice 2022;193:110121. [DOI: 10.1016/j.diabres.2022.110121] [Reference Citation Analysis]
3 Hernández-Rodríguez M, Clemente CF, Macías-Pérez ME, Rodríguez-Fonseca RA, Vázquez MIN, Martínez J, Ruvalcaba RM, Rosas MM, Jiménez EM. Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology. Pharmacol Rep 2022. [PMID: 36042131 DOI: 10.1007/s43440-022-00405-9] [Reference Citation Analysis]
4 Satoh-asahara N, Yamakage H, Tanaka M, Kawasaki T, Matsuura S, Tatebe H, Akiguchi I, Tokuda T. Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of diabetic patients based on their cognitive status.. [DOI: 10.1101/2022.07.07.22277348] [Reference Citation Analysis]
5 Shin HJ, Jin Z, An HS, Park G, Lee JY, Lee SJ, Jang HM, Jeong EA, Kim KE, Lee J, Yoo DY, Roh GS. Lipocalin-2 Deficiency Reduces Hepatic and Hippocampal Triggering Receptor Expressed on Myeloid Cells-2 Expressions in High-Fat Diet/Streptozotocin-Induced Diabetic Mice. Brain Sciences 2022;12:878. [DOI: 10.3390/brainsci12070878] [Reference Citation Analysis]
6 Tanaka M, Yamakage H, Muranaka K, Yamada T, Araki R, Ogo A, Matoba Y, Watanabe T, Saito M, Kurita S, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Matsumoto M, Nishimura M, Kusakabe T, Wada H, Hasegawa K, Kotani K, Noda M, Satoh-asahara N. Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1. Front Endocrinol 2022;13:880148. [DOI: 10.3389/fendo.2022.880148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Camacho-morales A. Glycolytic metabolism supports microglia training during age-related neurodegeneration. Pharmacol Rep. [DOI: 10.1007/s43440-022-00363-2] [Reference Citation Analysis]
8 Huang N, Huang J, Feng F, Ba Z, Li Y, Luo Y, Srivastava AS. Tanshinone ΙΙA-Incubated Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammation of N9 Cells through TREM2 Signaling Pathway. Stem Cells International 2022;2022:1-7. [DOI: 10.1155/2022/9977610] [Reference Citation Analysis]